Artificial Intelligence Platform for Molecular Targeted Therapy:A Translational Science Approach

分子靶向治疗的人工智能平台

生物工程

原   价:
1507.5
售   价:
1206.00
优惠
平台大促 低至8折优惠
发货周期:预计3-5周发货
作      者
出  版 社
出版时间
2021年03月12日
装      帧
精装
ISBN
9789811232305
复制
页      码
468 pp
语      种
英文
综合评分
暂无评分
我 要 买
- +
库存 30 本
  • 图书详情
  • 目次
  • 买家须知
  • 书评(0)
  • 权威书评(0)
图书简介
In the era of big biomedical data, there are many ways in which artificial intelligence (AI) is likely to broaden the technological base of the pharmaceutical industry. Cheminformatic applications of AI involving the parsing of chemical space are already being implemented to infer compound properties and activity. By contrast, dynamic aspects of the design of drug/target interfaces have received little attention due to the inherent difficulties in dealing with physical phenomena that often do not conform to simplifying views. This book focuses precisely on dynamic drug/target interfaces and argues that the true game change in pharmaceutical discovery will come as AI is enabled to solve core problems in molecular biophysics that are intimately related to rational drug design and drug discovery. Here are a few examples to convey the flavor of our quest: How do we therapeutically impair a dysfunctional protein with unknown structure or regulation but known to be a culprit of disease? In regards to SARS-CoV-2, what is the structural impact of a dominant mutation?, how does the structure change translate into a fitness advantage?, what new therapeutic opportunity arises? How do we extend molecular dynamics simulations to realistic timescales, to capture the rare events associated with drug targeting in vivo? How do we control specificity in drug design to selectively remove side effects? This is the type of problems, directly related to the understanding of drug/target interfaces, that the book squarely addresses. Key Features • The book introduces the conceptual and representational framework that enables an AI-empowered platform to design drug/target interfaces with experimentally tested or testable outcomes • The book introduces a deep learning technology for drug design that deals with dynamic ligand/target interfaces, essentially teaching drugs to target structurally adaptable proteins • By constructing a suitable AI platform, the book teaches how to extend/propagate molecular dynamics computations to cover realistic timescales in order to capture rare events identified with molecular targeting in vivo
本书暂无推荐
本书暂无推荐
看了又看
  • 上一个
  • 下一个